/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Momenta Pharmaceuticals Inc.\n \n\n\n\n\n
Nov 23 10:44 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 12, 2009 12:00 PM EST
\n\n \n Momenta Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference - GlobeNewswire\n \n \n
\n\n Nov 10, 2009 2:01 AM EST
\n\n \n Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE(R)-Related Patents - Business Wire\n \n \n
\n\n Nov 05, 2009 8:32 AM EST
\n\n \n Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2009 - GlobeNewswire\n \n \n
\n\n Oct 30, 2009 8:01 AM EDT
\n\n \n Momenta Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference - GlobeNewswire\n \n \n
\n\n Oct 29, 2009 11:38 AM EDT
\n\n \n Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2009 Financial Results - GlobeNewswire\n \n \n
\n\n Sep 28, 2009 1:23 PM EDT
\n\n \n Momenta Pharmaceuticals, Inc. Announces Closing of Offering and Exercise of Over-Allotment Option - GlobeNewswire\n \n \n
\n\n Sep 24, 2009 2:45 PM EDT
\n\n \n Momenta Pharmaceuticals Announces Positive Results From M118 EMINENCE Trial - GlobeNewswire\n \n \n
\n
\n\n");